Testing effectiveness (Phase 2)Looking for participantsNCT06322095
What this trial is testing
GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors
Who this might be right for
Patients With Advanced Solid TumorAdvanced Solid Tumor With Oncogenic Driver Mutations
Suzhou Genhouse Bio Co., Ltd. 72